Member Info for Bobbler

Glen F. Very Fair and decent reply 👍

Baliff, I believe the target cancers ref treatment are the same.

The strongest cancer response was seen in haematological cancers, with significant unmet medical need, including T-ALL and B-cell lymphoma.1

Looking at the news this morning I would say we’ve missed this boat.

https://www.bbc.co.uk/news/articles/cj38ymeyg4mo.amp

Laz: I am mystified that so-called investors here do not seem to understand that most business operations have operational and developmental setbacks during their growth periods.

I can assure you I am so call investor and have been since 2009.

I’m mystified that you think the length of the “growth” period is acceptable. SAR needs a very large pill, and quickly.

GlenF. Maybe I’m being overly pessimistic after so many years. But I don’t feel confident when I read statements about spending money on “business development consultants “ to accelerate ongoing partnering discussions. Surely that it what SP should be doing.

Laz, what news are we following? Bit pied piper

Laz, that’s very sound advice. Sell and buy back later. You can ramp this as much as you wish.

Unless another RNs with real news materialises then I won’t be surprised if this drops to single figures by year end. What a shambles they have made of this company. How can the board be taken seriously if they make statements claiming to have made significant progress in the past year? It’s a joke now.

Nav, something that would add value. I don’t think this will.

“the Company has made significant operational progress, including the appointment of a leading global contract research organisation (CRO),”

So, appointing a company and paying them for a service is the key achievement for justifying the huge bonuses.

Just sounds like waffle.

Warty, can’t reassure you that we are getting value for our money today, but tomorrow might be a different story.

Celtic, they might not have a choice. If there is an issue with the science then it’s going to be very difficult to raise future funds. I would bet my last pound that these guys aren’t likely to fund the business until it sorts itself out (like many Small business owners do). They don’t strike me as the kind of guys who would stop drawing salaries. Any serious problems with the molecules and they will d fail to raise and my guess is stop all future R &D expenditure and ride it out as long as the cash lasts. They have no interest in share holders, self serving and nothing more. I used to believe in the science, frankly that was misguided. Twenty years and no takers, doesn’t suggest these are at the top of their game.

I think it’s bust now. Just hoping pharma will come along and take a punt at 35p share buy out. But reality is they could wait until it’s delisted, about to go into receivership and get the IP for next to nothing.

Late start, Round of golf, long lunch and then early finish.

The science is completed now, the only work left is to organise endless overseas jolly’s and then the pain of organising the queue. Which can sometimes be difficult as the partners and buyers are often fighting with each other to get first dabs on the first in class molecules. Fear of being left behind sends them wild.

All this effort needs significant financial reward.

It’s a shambolic mess. SP needs to go, there is no evidence of any potential partnership. “We continue to talk to interested parties”. Anybody can make that comment. Seriously, ask yourself, if you were a potential partner, would you be confident that this was going places?

It’s 19801, but we can’t say what it is……..nothing rings true anymore.

I know Rome wasn’t built in a day, but 21 years and so far not much to shout about. A lot of salary and pension contributions for what?

the generic, post patent version will be available from china before they get their ****e together 😂

Dickpuller, on £8k of trades I wouldn’t say the MM’s are wining much. I doubt the margin/commissions would cover a decent lunch.

Warty, I couldn’t agree more. I’ve always been optimistic and generally positive towards SAR and the BOD. But it’s become a comedy, one fcuk up after another. In any other scenario they would either be sacked, or if was their own business (money) they would have gone into receivership. But they are pretty much protected from those out comes with no financial risk attached. It’s essentially other people’s money they are living off and in some cases wasting. What has SP done? If someone could please point out the financial benefits of having him on board. And don’t say he got an improved package for 737 because an increase share of nothing benefits no one. And let’s be honest they can’t give that away. The lack of comms tells me there is zero good news. The appointment of another broker may well be because the incumbent told them something they didn’t want to hear “no chance of raising cash”.

Potnak, what do you think the strategy is then?

Run it into the ground and sell it off?